Radiation Therapy Devices Sales

Radiation Therapy Devices Sales Market Outlook

The global Radiation Therapy Devices market was valued at approximately USD 6 billion in 2023 and is projected to reach around USD 9 billion by 2035, growing at a CAGR of about 5% during the forecast period. This growth is driven by increasing cancer prevalence worldwide, advancements in radiation therapy technologies, and the rising demand for effective treatment options among healthcare providers. Furthermore, the ongoing investments in the healthcare sector to enhance cancer treatment facilities and the growing emphasis on early-stage cancer diagnosis are expected to play a significant role in propelling market growth. The integration of artificial intelligence and machine learning in radiation therapy systems is also transforming treatment methodologies, leading to improved patient outcomes and heightened adoption of these devices across various healthcare settings.

Growth Factor of the Market

The growth of the Radiation Therapy Devices market is significantly influenced by various factors, primarily the increasing global incidence of cancer. As per the World Health Organization, the number of new cancer cases is expected to rise to 27 million by 2030, necessitating enhanced treatment modalities such as radiation therapy. Additionally, technological advancements in radiation therapy devices are paving the way for more precise and effective treatment options. For instance, the introduction of image-guided and intensity-modulated radiation therapy has revolutionized the way cancer is treated, reducing side effects and improving recovery rates. Moreover, the growing healthcare expenditure in emerging economies has led to the establishment of new cancer treatment centers, thereby augmenting the demand for radiation therapy devices. The favorable reimbursement policies in many regions also add to the market's appeal, encouraging healthcare institutions to adopt advanced therapy solutions. Furthermore, the collaboration between research institutions and healthcare companies to innovate and develop new devices is expected to fuel market growth in the coming years.

Key Highlights of the Market

• The global Radiation Therapy Devices market is projected to grow from USD 6 billion in 2023 to USD 9 billion by 2035.
• Technological advancements in radiation therapy devices are driving the market growth.
• Increasing prevalence of cancer worldwide is a major growth driver for the market.
• Emerging economies are witnessing significant investments in healthcare infrastructure.
• Collaborations between research institutions and companies are leading to innovations in radiation therapy technologies.

By Product Type

External Beam Radiation Therapy Devices:

External Beam Radiation Therapy (EBRT) devices dominate the market, accounting for a significant share due to their widespread adoption in various healthcare facilities. These devices deliver radiation from outside the body to target cancer cells specifically while sparing surrounding healthy tissues. Advancements in EBRT technologies, such as linear accelerators and intensity-modulated radiation therapy, have enhanced treatment efficacy, driving their demand further. Furthermore, the increasing number of cancer cases requiring EBRT is pushing healthcare facilities to invest in these devices, contributing to market growth.

Internal Radiation Therapy Devices:

Internal Radiation Therapy, or brachytherapy, is another prominent segment in the radiation therapy devices market. Brachytherapy involves placing a radioactive source inside or close to the tumor, allowing for higher doses of radiation to the tumor while minimizing exposure to surrounding tissues. This method is particularly effective for localized cancers such as prostate cancer and cervical cancer, leading to its increased adoption. The growing preference for patient-friendly procedures with reduced recovery times is also steering demand toward internal radiation therapy devices.

Systemic Radiation Therapy Devices:

Systemic Radiation Therapy involves using radioactive substances administered through the bloodstream to target cancer cells throughout the body. This method is particularly used for treating thyroid cancer and certain types of lymphoma. The increasing awareness and acceptance of systemic therapy options among healthcare professionals are propelling the market for these devices. Additionally, advancements in drug formulations and delivery mechanisms are expected to further enhance the efficacy of systemic radiation therapy, contributing to its market growth.

Orthovoltage Radiation Therapy Devices:

Orthovoltage Radiation Therapy devices, which utilize low-energy X-rays for treatment, are gaining traction particularly for superficial tumors and conditions. While their use has diminished with the advent of higher energy devices, they still hold significance in specific applications, particularly in dermatologic treatments and palliative care. This segment remains relevant in developing regions where access to advanced technology may be limited, thus sustaining its presence in the overall market.

Brachytherapy Devices:

Brachytherapy devices have emerged as a critical component of the radiation therapy market due to their targeted approach. They are widely used for treating various cancers such as prostate, breast, and cervical cancers. The increasing preference for localized treatment methods that minimize damage to healthy tissues drives the demand for brachytherapy devices. Moreover, ongoing advancements in brachytherapy techniques, including the use of biodegradable materials and advancements in imaging technology, are expected to foster growth within this segment.

By Application

Hospitals:

Hospitals are the primary users of radiation therapy devices due to their comprehensive cancer treatment facilities and access to advanced medical technologies. The increasing number of cancer cases being treated in hospitals significantly influences the demand for radiation therapy devices. Hospitals are equipped with a diverse range of radiation therapy technologies, allowing them to provide personalized treatment plans based on the specific needs of patients. The trend towards establishing specialized cancer centers within hospitals is further driving the market, as these centers often require a higher number of advanced radiation therapy devices.

Cancer Treatment Centers:

Cancer treatment centers are dedicated facilities focusing on providing targeted cancer care, driving the demand for radiation therapy devices. These centers cater specifically to cancer patients with tailored treatment options, including radiation therapy. As a result, they are often at the forefront of adopting the latest technologies to enhance treatment outcomes and patient care. The increasing establishment and expansion of cancer treatment centers globally are expected to significantly contribute to the market growth of radiation therapy devices.

Specialty Clinics:

Specialty clinics provide focused cancer treatment and are emerging as vital players in the radiation therapy devices market. These clinics often offer personalized care and specialized treatments that cater to the unique needs of patients. The demand for radiation therapy devices in specialty clinics is growing due to their ability to provide advanced treatment options and improved patient experiences. Their flexibility in adopting new technologies and treatment methodologies to enhance patient outcomes further drives the market.

Research Institutes:

Research institutes play a crucial role in the development and innovation of radiation therapy devices, contributing to the overall market growth. These institutions are involved in clinical trials, research studies, and the development of next-generation therapies, fostering advancements in technology. Collaborations between research institutes and healthcare providers lead to the introduction of innovative radiation therapy solutions. The increasing investment in cancer research and development is expected to further bolster the demand for radiation therapy devices coming from this segment.

Others:

This category encompasses various other applications where radiation therapy devices are utilized. These applications may include academic institutions, home healthcare settings, and palliative care units that require radiation therapy for pain relief. The growing recognition of the benefits of radiation therapy in diverse settings is driving the demand for devices beyond traditional healthcare facilities, contributing to the overall market growth.

By Distribution Channel

Direct Sales:

Direct sales represent a significant distribution channel for radiation therapy devices, as manufacturers often prefer to sell their products directly to healthcare facilities. This approach allows manufacturers to build strong relationships with customers, provide tailored solutions, and offer comprehensive training on device usage. The growing trend of hospitals and cancer treatment centers purchasing directly from manufacturers is driving the demand for direct sales in the market.

Distributor Sales:

Distributor sales are another critical channel for radiation therapy devices, providing manufacturers with broader market access and leveraging established distribution networks. Distributors facilitate the sale of devices to various healthcare facilities, including hospitals and clinics, ensuring timely delivery and accessibility. This channel is particularly beneficial for manufacturers looking to enter new markets without significant investment in sales teams, thus contributing to market growth.

Online Sales:

Online sales have emerged as a growing distribution channel for radiation therapy devices, allowing manufacturers and distributors to reach a wider audience. The convenience and accessibility of online purchasing are attracting healthcare providers to explore digital marketplaces for their equipment needs. As the healthcare sector increasingly adopts digital solutions, online sales are expected to play an essential role in the distribution of radiation therapy devices, enhancing overall market presence.

Retail Pharmacies:

Retail pharmacies are involved in the distribution of certain radiation therapy products, particularly those related to palliative care or supportive treatments. Although their role is smaller compared to hospitals and specialized clinics, the presence of radiation therapy products in retail pharmacies is gradually increasing. This segment primarily serves patients seeking immediate access to supportive care products, contributing to the market's overall diversity.

Others:

This category includes various alternative distribution channels for radiation therapy devices, such as home healthcare agencies or specialized medical equipment rental companies. These channels are gaining traction as more patients seek outpatient care or home-based treatment options. The rising trend of personalized medicine and the shift towards patient-centered care are driving this segment, highlighting the importance of diverse distribution channels in the radiation therapy devices market.

By Technology Type

Intensity-Modulated Radiation Therapy (IMRT):

Intensity-Modulated Radiation Therapy (IMRT) is a sophisticated technique that uses computer-controlled linear accelerators to deliver precise radiation doses to a malignant tumor while minimizing exposure to surrounding healthy tissues. This technology has gained immense popularity due to its ability to provide highly targeted treatment, leading to improved patient outcomes and reduced side effects. The growing preference for personalized and advanced treatment options among healthcare providers is driving the demand for IMRT in the radiation therapy devices market.

Image-Guided Radiation Therapy (IGRT):

Image-Guided Radiation Therapy (IGRT) enhances the accuracy of radiation delivery by using imaging technologies to visualize the tumor before treatment. This technique allows clinicians to make real-time adjustments, ensuring the radiation is delivered precisely to the intended location. The increasing focus on improving treatment accuracy and minimizing side effects is bolstering the adoption of IGRT. Furthermore, advancements in imaging technologies, such as MRI and CT scans, are expected to drive further growth in this segment.

Stereotactic Radiosurgery:

Stereotactic radiosurgery is a non-invasive treatment option that delivers highly focused radiation beams to target tumors with minimal damage to surrounding healthy tissue. It is commonly used for treating brain tumors and other conditions where precision is crucial. The growing recognition of stereotactic radiosurgery as an effective treatment modality is driving its demand in the market. Additionally, advancements in technology and increased clinical applications for this method are expected to enhance market growth.

Proton Therapy:

Proton therapy is an advanced form of radiation treatment that uses protons rather than conventional X-rays to irradiate cancer cells. This technology offers several advantages, including reduced exposure to healthy tissues and organs, making it particularly effective for treating pediatric cancers and tumors located near critical structures. The increasing awareness and acceptance of proton therapy among clinicians and patients are driving the demand for proton therapy devices. Ongoing research and clinical trials aimed at demonstrating its effectiveness are also expected to contribute to market growth.

Others:

This category includes various other radiation therapy technologies that are gaining traction due to ongoing innovations. These may comprise novel techniques such as radionuclide therapy and neutron capture therapy, which are being explored in clinical settings. The continuous advancement in radiation therapy technologies is contributing to the development of new treatment options that address specific patient needs, thereby fostering the growth of this segment in the market.

By Modulated Radiation Therapy

Conventional Modulated Radiation Therapy:

Conventional modulated radiation therapy is widely used in clinical practice and forms the backbone of various treatment protocols. This technique allows for adjusting the radiation dose distribution to match the shape and size of the tumor, leading to improved targeting. The ease of implementation and established efficacy of conventional modulated radiation therapy ensure its continued presence in the market. As clinicians become increasingly aware of the benefits of personalized radiation therapy, this segment is expected to maintain a robust demand.

Advanced Modulated Radiation Therapy:

Advanced modulated radiation therapy encompasses newer technologies, such as volumetric modulated arc therapy (VMAT) and adaptive radiation therapy, which offer more precise and flexible treatment options. These advanced techniques utilize sophisticated algorithms and imaging technologies to adapt treatment plans in real time, improving accuracy and patient outcomes. The increasing trend toward personalized medicine and the demand for improved treatment efficacy are driving the adoption of advanced modulated radiation therapy devices in the market.

By Guided Radiation Therapy

Image-Guided Radiation Therapy (IGRT):

Image-Guided Radiation Therapy (IGRT) has been evaluated as one of the most effective means of guiding radiation therapy delivery. This approach utilizes imaging technologies, such as CT scans or MRI, to visualize the tumor in real-time and adjust the radiation delivery accordingly. The growing recognition of the importance of accuracy in radiation therapy is driving the demand for IGRT devices in the market. Enhanced patient outcomes associated with IGRT have made it a preferred choice among healthcare providers, further promoting its market growth.

Ultrasound-Guided Radiation Therapy:

Ultrasound-guided radiation therapy is an emerging technology that uses ultrasound imaging to monitor tumor movement and adjust radiation delivery. This method is particularly advantageous for tumors that may shift position during treatment, such as those in the abdomen. The increasing application of ultrasound in cancer treatment is expected to drive the demand for ultrasound-guided radiation therapy devices. As technology continues to evolve, the integration of ultrasound with radiation therapy is anticipated to enhance treatment accuracy and improve patient outcomes.

By Region

The North American region is currently the largest market for radiation therapy devices, accounting for approximately 40% of the global market share. The high demand can be attributed to advanced healthcare infrastructure, a strong presence of key market players, and an increasing number of cancer cases. Additionally, the region’s focus on research and development, along with favorable reimbursement policies, bolsters the growth of the market. The market in North America is expected to witness a CAGR of 5.5% during the forecast period, driven by continued innovations and expansion of treatment facilities.

In contrast, the Asia Pacific region is projected to exhibit the highest growth rate during the forecast period, with an anticipated CAGR of 6% from 2025 to 2035. This growth is primarily fueled by the rising prevalence of cancer, increased government investments in healthcare, and the expanding middle class seeking quality healthcare services. The demand for radiation therapy devices is growing in countries such as China and India, where the establishment of new cancer treatment facilities and advancements in healthcare technology are significantly boosting market potential.

Opportunities

The Radiation Therapy Devices market presents significant opportunities for growth, particularly in emerging economies where healthcare infrastructure is rapidly developing. As these regions witness a rise in cancer cases, there is an increasing demand for advanced treatment options, including radiation therapy. This presents an opportunity for manufacturers to expand their presence and cater to the needs of healthcare providers in these markets. Establishing collaborations with local healthcare facilities and government agencies to enhance access to radiation therapy technologies can further strengthen market opportunities. Additionally, investing in training and education programs for healthcare professionals in emerging regions can facilitate the adoption of advanced radiation therapy techniques, creating mutual benefits for both manufacturers and healthcare providers.

Another key opportunity lies in the ongoing technological advancements within the radiation therapy devices market. The continuous evolution of treatment modalities, such as proton therapy and stereotactic radiosurgery, offers the potential for improved patient outcomes and reduced side effects. Companies that focus on research and development to innovate and enhance their product offerings stand to gain a competitive edge in the market. Furthermore, expanding into niche markets, such as pediatric oncology or personalized medicine, can unlock new growth avenues. As patient-centric approaches become more prevalent, there is a growing demand for customized radiation therapy solutions tailored to individual patient needs, presenting a unique opportunity for manufacturers to differentiate themselves in a competitive landscape.

Threats

Despite the promising growth trajectory, the Radiation Therapy Devices market faces several threats that could hinder its progress. One of the most significant challenges is the stringent regulatory environment surrounding medical devices. Companies must navigate complex approval processes and ensure compliance with safety and efficacy standards set by regulatory authorities, which can lead to delays in product launches and increased costs. Additionally, rapid technological advancements within the industry mean that companies must continually invest in research and development to keep pace with competitors, which may strain financial resources. Furthermore, the emergence of alternative cancer treatment modalities, such as immunotherapy and targeted therapies, poses a threat to the traditional radiation therapy market by providing patients with more options that could be perceived as less invasive or more effective.

Moreover, rising healthcare costs and budget constraints faced by healthcare providers may lead to reduced spending on advanced treatment technologies, impacting the overall market demand. Economic downturns and fluctuations in healthcare funding can further exacerbate this situation. Additionally, the global nature of the market exposes companies to geopolitical risks, such as trade restrictions and tariffs, which can disrupt supply chains and affect product availability. Finally, the increasing prevalence of cyber threats and data breaches in the healthcare sector represents a growing concern for manufacturers, as they must invest in securing their technologies and maintaining patient confidentiality.

Competitor Outlook

• Varian Medical Systems
• Siemens Healthineers
• Philips Healthcare
• Accuray Incorporated
• GE Healthcare
• Hitachi Medical Corporation
• Canon Medical Systems
• ViewRay, Inc.
• Bracco Imaging S.p.A.
• Radiation Therapy Oncology Group (RTOG)
• Mevion Medical Systems
• AECL (Atomic Energy of Canada Limited)
• Mirada Medical
• RaySearch Laboratories
• IBA Group

The competitive landscape of the Radiation Therapy Devices market is characterized by a mix of established players and emerging innovators. Major companies such as Varian Medical Systems, Siemens Healthineers, and Philips Healthcare are at the forefront, driving advancements in radiation therapy technology. These companies leverage their extensive research and development capabilities to introduce innovative solutions that enhance treatment efficacy and improve patient experiences. Their established market presence and strong distribution networks further enable them to maintain a competitive edge. Additionally, these players are increasingly focusing on strategic collaborations and partnerships to expand their product offerings and market reach.

Emerging companies like Accuray Incorporated and ViewRay, Inc. are also making significant strides in the market by introducing novel radiation therapy solutions, such as stereotactic radiosurgery and MRI-guided radiation therapy. These innovations have garnered attention from healthcare providers seeking cutting-edge technologies to improve patient outcomes. The growing emphasis on personalized medicine and patient-centric approaches has prompted these companies to tailor their products to meet the specific needs of patients, driving their market growth. Furthermore, the increasing number of cancer treatment centers and hospitals seeking advanced technologies presents ample opportunities for these emerging players to capture market share.

In addition to established and emerging players, collaboration among industry stakeholders, including research institutions, academic bodies, and healthcare providers, is fostering innovation in the radiation therapy devices market. These collaborations are essential for advancing research, conducting clinical trials, and developing next-generation technologies that address unmet needs in cancer treatment. The competitive landscape is also witnessing heightened focus on regulatory compliance, as companies strive to meet stringent safety and effectiveness standards for their devices. Overall, the Radiation Therapy Devices market is expected to remain dynamic, with ongoing innovations and a competitive environment shaping its future.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 IBA Group
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 GE Healthcare
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 ViewRay, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Mirada Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Philips Healthcare
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Accuray Incorporated
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Siemens Healthineers
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Bracco Imaging S.p.A.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Canon Medical Systems
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Mevion Medical Systems
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 RaySearch Laboratories
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Varian Medical Systems
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Hitachi Medical Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 AECL (Atomic Energy of Canada Limited)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Radiation Therapy Oncology Group (RTOG)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Radiation Therapy Devices Sales Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Cancer Treatment Centers
    • 6.1.3 Specialty Clinics
    • 6.1.4 Research Institutes
    • 6.1.5 Others
  • 6.2 Radiation Therapy Devices Sales Market, By Product Type
    • 6.2.1 External Beam Radiation Therapy Devices
    • 6.2.2 Internal Radiation Therapy Devices
    • 6.2.3 Systemic Radiation Therapy Devices
    • 6.2.4 Orthovoltage Radiation Therapy Devices
    • 6.2.5 Brachytherapy Devices
  • 6.3 Radiation Therapy Devices Sales Market, By Technology Type
    • 6.3.1 Intensity-Modulated Radiation Therapy (IMRT)
    • 6.3.2 Image-Guided Radiation Therapy (IGRT)
    • 6.3.3 Stereotactic Radiosurgery
    • 6.3.4 Proton Therapy
    • 6.3.5 Others
  • 6.4 Radiation Therapy Devices Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales
    • 6.4.3 Online Sales
    • 6.4.4 Retail Pharmacies
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Radiation Therapy Devices Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Radiation Therapy Devices Sales market is categorized based on

By Product Type

• External Beam Radiation Therapy Devices
• Internal Radiation Therapy Devices
• Systemic Radiation Therapy Devices
• Orthovoltage Radiation Therapy Devices
• Brachytherapy Devices

By Application

• Hospitals
• Cancer Treatment Centers
• Specialty Clinics
• Research Institutes
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales
• Online Sales
• Retail Pharmacies
• Others

By Technology Type

• Intensity-Modulated Radiation Therapy (IMRT)
• Image-Guided Radiation Therapy (IGRT)
• Stereotactic Radiosurgery
• Proton Therapy
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Varian Medical Systems
• Siemens Healthineers
• Philips Healthcare
• Accuray Incorporated
• GE Healthcare
• Hitachi Medical Corporation
• Canon Medical Systems
• ViewRay, Inc.
• Bracco Imaging S.p.A.
• Radiation Therapy Oncology Group (RTOG)
• Mevion Medical Systems
• AECL (Atomic Energy of Canada Limited)
• Mirada Medical
• RaySearch Laboratories
• IBA Group